Redcare Pharmacy (SAE) Financial Statements
Redcare Pharmacy Financial Overview
Redcare Pharmacy's market cap is currently $1.31B. The company's EPS TTM is $-1.69; its P/E ratio is -44.90; Redcare Pharmacy is estimated to report earnings on March 3, 2027, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 2.94B | $ 2.37B | $ 1.80B | $ 1.20B | $ 1.06B |
| Gross Profit | $ 593.70M | $ 545.78M | $ 440.38M | $ 331.79M | $ 266.53M |
| Operating Income | $ -23.80M | $ -38.99M | $ -17.30M | $ -69.17M | $ -65.70M |
| EBITDA | $ 45.60M | $ 28.03M | $ 50.94M | $ -30.64M | $ -37.37M |
| Net Income | $ -37.70M | $ -45.46M | $ -12.04M | $ -77.65M | $ -74.19M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 203.50M | $ 177.56M | $ 204.16M | $ 184.00M | $ 283.46M |
| Total Assets | $ 1.25B | $ 1.00B | $ 1.02B | $ 729.47M | $ 783.08M |
| Total Debt | $ 415.60M | $ 247.38M | $ 244.84M | $ 255.19M | $ 236.43M |
| Net Debt | $ 323.20M | $ 150.77M | $ 161.06M | $ 188.75M | $ -10.61M |
| Total Liabilities | $ 767.30M | $ 493.31M | $ 469.56M | $ 374.84M | $ 367.66M |
| Stockholders' Equity | $ 459.20M | $ 483.98M | $ 522.19M | $ 354.63M | $ 415.41M |
| Cash Flow | |||||
| Free Cash Flow | $ -56.30M | $ 13.38M | $ 23.23M | $ -82.64M | $ -31.52M |
| Operating Cash Flow | $ 23.00M | $ 22.13M | $ 61.46M | $ -29.11M | $ 11.63M |
| Investing Cash Flow | $ -151.40M | $ 8.38M | $ -59.96M | $ -138.01M | $ -84.30M |
| Financing Cash Flow | $ 124.10M | $ -17.94M | $ 15.05M | $ -13.52M | $ 229.59M |
Currency in EUR
